National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/26/2021 release of VAERS data:

Found 2,908 cases where Vaccine is COVID19 and Symptom is COVID-19 and Patient Died

Government Disclaimer on use of this data



Case Details (Sorted by Age)

This is page 19 out of 291

Result pages: prev   10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28   next


VAERS ID: 1086803 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-03-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Kidney transplant
Allergies:
Diagnostic Lab Data:
CDC Split Type: ILPFIZER INC2021240115

Write-up: got sick with Corona ,one of them also died; got sick with Corona ,one of them also died; This is a spontaneous report from a contactable physician. The physician reported same event for four patients, this is the first of four reports. A male patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date at SINGLE DOSE of first dose, via an unspecified route of administration on an unspecified date at SINGLE DOSE of second dose for covid-19 immunisation. Medical history included kidney transplant. The patient''s concomitant medications were not reported. The patient received 2 doses of BNT162b2 and got sick with Corona and died. The patient died on an unspecified date. It was not reported if an autopsy was performed. Information about Batch/Lot number has been requested.; Sender''s Comments: Based on the limited information provided, the Company (Pfizer) cannot exclude that the suspect medication may have contributed to the reported events in this patient. Additional information regarding onset dates of drug administration/ events and concomitant medications will aid in comprehensive assessment of the case. The impact of this report on the benefit-risk profile of the Pfizer product and on the conduct of the study is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, ethics committees. and investigators, as appropriate.,Linked Report(s) : IL-PFIZER INC-2021240116 same drug/event in different patients;IL-PFIZER INC-2021240117 same drug/event in different patients;IL-PFIZER INC-2021240118 same drug/event in different patients; Reported Cause(s) of Death: got sick with Corona ,one of them also died; got sick with Corona ,one of them also died


VAERS ID: 1089835 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-11
Onset:2021-01-12
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-03-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-01-12
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Malignant neoplasm of pancreas (stent implantation)
Preexisting Conditions: Medical History/Concurrent Conditions: Abdominal pain (patient was admitted to hospital); Fever (unknown reason); Suspected COVID-19 (two days fever, loss of smell)
Allergies:
Diagnostic Lab Data: Test Date: 20201230; Test Name: covid; Test Result: Negative
CDC Split Type: CZPFIZER INC2021250705

Write-up: sudden death/death after vaccination; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority-WEB CZ-CZSUKL-21001643. A 78-year-old male patient received his first dose of BNT162B2 (COMIRNATY), via an unspecified route of administration on 11Jan2021 at single dose for covid-19 immunisation. Medical history included abdominal pain from 23Dec2020 and patient was admitted to hospital. On 30Dec2020, the patient was diagnosed with pancreatic tumour. It was decided to not operate. Stent was applied instead. Three patients from the same room was tested as Covid-19 positive, the patient was negative on 30Dec2020. He might have been Covid-19 positive in Oct2020 (two days fever, loss of smell), but was not tested that day. On 08Jan2021 the patient had fever, unknown reason. Concomitant drugs were not reported. The patient experienced sudden death/death after vaccination on 12Jan2021. The event was serious for death, hospitalization, medical significant, and life-threatening. The cause of death was unknown. According to a physician, patient was not at terminal stage, preparation for home care with perspective of 3 months. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: unknown cause of death


VAERS ID: 1089902 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-19
Onset:2021-02-04
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-03-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM0477 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, Oxygen saturation
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Living in nursing home
Allergies:
Diagnostic Lab Data: Test Date: 20210204; Test Name: desaturation; Test Result: 80 %
CDC Split Type: FRPFIZER INC2021250318

Write-up: COVID-19 respiratory infection; COVID-19 respiratory infection; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB (FR-AFSSAPS-MA20210612). A 98-year-old female patient received the first dose of BNT162B2 (COMIRNATY; Lot number: EM0477), intramuscularly, on 19Jan2021 (at the age of 98-years-old) at a single dose for COVID-19 immunisation. Medical history included living in nursing home. The patient''s concomitant medications were not reported. The patient experienced COVID-19 respiratory infection on 04Feb2021, which was reported as fatal. It was reported that on day 16 of vaccination (day 1), there was appearance of a COVID-19 infection with 80% desaturation on 04Feb2021. The patient died on an unspecified date. The cause of death was assessed as COVID-19. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: COVID-19


VAERS ID: 1094268 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-21
Onset:2021-01-01
Submitted: 0000-00-00
Entered: 2021-03-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK4243 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Confusional state, Drug ineffective, Dyspnoea, Heart rate, Heart rate decreased, SARS-CoV-2 test, Seizure
SMQs:, Anaphylactic reaction (broad), Lack of efficacy/effect (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Dementia (broad), Convulsions (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Generalised convulsive seizures following immunisation (narrow), Hypoglycaemia (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-04
   Days after onset: 62
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? Yes
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 2021; Test Name: Heart rate; Result Unstructured Data: Test Result:decreased; Test Date: 20210304; Test Name: COVID-19 virus test; Test Result: Positive
CDC Split Type: GBPFIZER INC2021246577

Write-up: Confusion; shortness of breath; seizure; SARS-CoV-2 infection; SARS-CoV-2 infection; Seizures; Heart rate drop; This is a spontaneous report from a contactable consumer received from the Regulatory Agency. The Regulatory Authority report number is GB-MHRA-WEBCOVID-202103061608463700. Safety Report Unique Identifier GB-MHRA-ADR 24889457. An 85-year-old male patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech, Lot# Ek4243), via an unspecified route of administration, on 21Jan2021, at single dose, for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. Patient had not had symptoms associated with COVID-19, did not have a COVID-19, was not enrolled in clinical trial. The patient experienced seizure in Jan2021 with outcome of unknown , sars-cov-2 infection (death) on 04Mar2021 with fatal outcome on 04Mar2021, confusion (non-serious) on 23Jan2021 with outcome of unknown, seizures (non-serious) on 23Jan2021 with outcome of unknown. It was reported that the patient had a seizure overnight in Jan2021, ended up confused (on 23Jan2021) and short of breathe. He was admitted to hospital and treated with antibiotics. Patient had 2nd seizure and was treated for further infection. 3rd seizure just over a week later with continued confusion. Heart rate dropped. Patient tested positive and passed away. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: SARS-CoV-2 infection; SARS-CoV-2 infection


VAERS ID: 1094669 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-09
Onset:2021-02-01
Submitted: 0000-00-00
Entered: 2021-03-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK9788 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, COVID-19 pneumonia, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-22
   Days after onset: 21
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: PANTOPRAZOLE; XARELTO; IMOVANE; DIFFU K; PREGABALIN; FUROSEMIDE; TRIMEBUTINE; VENTOLINE [SALBUTAMOL SULFATE]; SERESTA; RAMIPRIL; BISOPROLOL HEMIFUMARATE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: AFib; Cataract; Coxarthrosis; Erysipelas; Fall; Hand osteoarthritis; Osteoarthritis knee; Venous peripheral insufficiency
Allergies:
Diagnostic Lab Data: Test Date: 20210213; Test Name: SARS-CoV-2 PCR test; Test Result: Positive
CDC Split Type: FRPFIZER INC2021250323

Write-up: a positive SARS COVID 19 PCR test; COVID-19 aggravated; COVID-19 pneumonitis; This is a spontaneous report from a contactable physician downloaded from the Regulatory Agency-WEB (FR-AFSSAPS-AM20210427). A 96-year-old female received BNT162B2 (COMIRNATY), intramuscularly, first dose on 19Jan2021 (Lot number: EJ6788) and second dose on 09Feb2021 (Lot number: EK9788) in the left deltoid, both at a single dose for COVID-19 immunisation. Medical history included osteoarthritis knee, coxarthrosis, cataract, venous peripheral insufficiency, erysipelas, atrial fibrillation (AFib), hand osteoarthritis, and recurrent fall. The patient was not previously diagnosed with COVID-19. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN), rivaroxaban (XARELTO), zopiclone (IMOVANE), potassium chloride (DIFFU K), pregabalin (MANUFACTURER UNKNOWN) , furosemide (MANUFACTURER UNKNOWN), trimebutine (MANUFACTURER UNKNOWN), salbutamol sulfate (VENTOLINE), oxazepam (SERESTA), ramipril (MANUFACTURER UNKNOWN), and bisoprolol hemifumarate (MANUFACTURER UNKNOWN). The patient experienced a positive SARS COVID 19 PCR test and COVID-19 aggravated on 13Feb2021, which caused hospitalization on 13Feb2021 and were reported as fatal. The patient also experienced COVID-19 pneumonitis in Feb2021, which was reported with hospitalization and fatal. The clinical course was reported as follows: On 11Feb2021, the patient had an onset of fever and was hospitalized on 13Feb2021 before a positive SARS COVID-19 PCR test. There was clinical degradation thereafter, initiation of oxygen therapy and unspecified corticosteroid therapy on 14Feb2021. It was also reported that the patient experienced behavioral disorder and hallucinations from the first dose of the vaccine. The patient underwent lab tests and procedures which included SARS-CoV-2 PCR test: positive on 13Feb2021. The patient died on 22Feb2021. The cause of death was reported as COVID-19 pneumonitis. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: COVID-19 pneumonitis


VAERS ID: 1099516 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-15
Onset:2021-01-19
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-03-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1491 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, General physical health deterioration, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-30
   Days after onset: 11
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210119; Test Name: COVID-19 PCR test; Result Unstructured Data: Test Result:Positive
CDC Split Type: ATPFIZER INC2021242192

Write-up: Reduced general condition; COVID-19 respiratory infection; This is a spontaneous report from a contactable physician. This is a report received from the Regulatory Authority-WEB. Regulatory authority number AT-BASGAGES-2021-04874. An 88 years old female patient received the first dose of BNT162B2 (COMIRNATY, Lot. EL1491) at single dose, on 15Jan2021, for COVID-19 immunisation. Relevant medical history and concomitant medications were unknown. Post the vaccination, the patient has been tested for COVID-19 and resulted positive on 19Jan2021. On 22Jan2021, the patient experienced reduced general condition and died on 30Jan2021. Clinical outcome of reduced general condition and death was fatal. Cause of death was reported as COVID-19 respiratory infection. It was unknown if autopsy was done. Relatedness of drug to reaction(s)/event(s) for Comirnaty to all events, reported as Unassessable/Unclassifiable by BASGAGES. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: COVID-19 respiratory infection; Reduced general condition


VAERS ID: 1099517 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-15
Onset:2021-01-26
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-03-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1491 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Death, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-01
   Days after onset: 6
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Chemotherapy NOS
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210126; Test Name: COVID-19 PCR test; Result Unstructured Data: Test Result:Positive
CDC Split Type: ATPFIZER INC2021242190

Write-up: COVID-19 PCR test positive; Death; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB AT-BASGAGES-2021-04884. A 76-year-old female patient received the first dose of bnt162b2 (COMIRNATY) (Lot # EL1491), via an unspecified route of administration at single dose on 15Jan2021 for COVID-19 immunisation. Medical history included ongoing chemotherapy NOS. Concomitant medications were not reported. The patient experienced death NOS on 01Feb2021, COVID-19 PCR test positive on 26Jan2021. The patient underwent lab tests and procedures which included SARS-CoV-2 test: positive on 26Jan2021. The patient died on 01Feb2021 from COVID-19 respiratory infection. It was not reported if an autopsy was performed. Missing info on cause of death and possible underlying diseases. Clinical course was reportrd as follows: Since 01Jan2021 a COVID infection was circulated in the retirement home. All 12/14 deceased were tested positive for Sars-CoV2 by means of PCR. The patient of this AE report was also positive. Tested for Sars-CoV2 by means of PCR (26Jan2021), on 29Jan2021 in the hospital due to deterioration, died there on 01Feb2021. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: COVID-19 respiratory infection


VAERS ID: 1099540 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-18
Onset:2021-02-05
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-03-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM0477 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210205; Test Name: Covid-19 test; Result Unstructured Data: Test Result:Postive
CDC Split Type: BEPFIZER INC2021249391

Write-up: COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable physician. A patient of unspecified age and gender received the first single dose of BNT162B2 (COMIRNATY, lot number EM0477) on 18Jan2021, for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient was positive on 05Feb2021 with fatal outcome. The patient died on an unspecified date in 2021. It was not reported if an autopsy was performed. The cause of death was not reported. The patient only received the first dose as was too sick for the second dose. Follow-up attempts are not possible. No further information is expected.; Sender''s Comments: Based on the information available as reported at this point, a possible contributory role of the suspect product cannot be excluded for the reported event of positive for corona virus infection for the lack of efficacy of the vaccine. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to only the vaccine first dose is given. This impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly to regulatory authorities, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test


VAERS ID: 1099541 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-18
Onset:2021-02-05
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-03-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM0477 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210205; Test Name: Covid-19 test; Result Unstructured Data: Test Result:Positive
CDC Split Type: BEPFIZER INC2021249392

Write-up: positive COVID-19 test; positive COVID-19 test; This is a spontaneous report from a contactable physician. A patient of unspecified age and gender received the first dose of bnt162b2 (COMIRNATY, lot number EM0477, expiration date not reported) , via an unspecified route of administration on 18Jan2021 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was positive COVID-19 testo on 05Feb2021 with fatal outcome. The patient died on an unspecified date. It was not reported if an autopsy was performed. The cause of death was not reported. The patient only received the first dose as the patient was too sick for the second dose. Follow-up attemtps are not possible. No further information is expected.; Sender''s Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of COVID-19 virus test positive and drug ineffective due to temporal relationship. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: positive COVID-19 test; positive COVID-19 test


VAERS ID: 1099542 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-18
Onset:2021-02-11
   Days after vaccination:24
Submitted: 0000-00-00
Entered: 2021-03-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM0477 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210211; Test Name: COVID-19 virus test; Test Result: Positive
CDC Split Type: BEPFIZER INC2021249393

Write-up: COVID-19; COVID-19; This is a spontaneous report from a contactable physician. A patient of unspecified age and gender received the 1st dose of bnt162b2 (COMIRNATY, lot# EM0477), via an unspecified route of administration, on 18Jan2021, at single dose, for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient experienced COVID-19 on 11Feb2021 with fatal outcome on an unspecified date in 2021. It was not reported if an autopsy was performed. The patient underwent lab tests and procedures which included COVID-19 virus test: positive on 11Feb2021. No follow-up attempts are possible. No further information is expected.; Sender''s Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported event COVID-19 leading to fatal outcome based on the known safety profile. However considering the relatively short duration since the vaccine first dose is given, it is unlikely the patient would have fully developed immunity. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: COVID-19; COVID-19


Result pages: prev   10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=19&ESORT=AGE&SYMPTOMS=COVID-19&VAX=COVID19&DIED=Yes


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166